Shepherd Kaplan Krochuk’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-20,000
| Closed | -$74K | – | 284 |
|
|
2017
Q4 | $74K | Sell |
20,000
-41,609
| -68% | -$154K | 0.05% | 213 |
|
|
2017
Q3 | $252K | Buy |
61,609
+3,500
| +6% | +$14.3K | 0.21% | 127 |
|
|
2017
Q2 | $216K | Buy |
58,109
+19,500
| +51% | +$72.5K | 0.13% | 151 |
|
|
2017
Q1 | $160K | Buy |
38,609
+12,048
| +45% | +$49.9K | 0.08% | 175 |
|
|
2016
Q4 | $114K | Sell |
26,561
-17,080
| -39% | -$73.3K | 0.03% | 207 |
|
|
2016
Q3 | $429K | Hold |
43,641
| – | – | 0.09% | 148 |
|
|
2016
Q2 | $247K | Buy |
+43,641
| New | +$247K | 0.06% | 209 |
|
|
2014
Q3 | – | Sell |
-3,417
| Closed | -$66K | – | 609 |
|
|
2014
Q2 | $66K | Sell |
3,417
-2,083
| -38% | -$40.2K | 0.01% | 509 |
|
|
2014
Q1 | $99K | Buy |
+5,500
| New | +$99K | 0.01% | 494 |
|